Maryline Kienle

Maryline Kienle is an accomplished researcher with extensive experience in organic chemistry and drug discovery. Currently serving as the Head of Research Operations & External Programs at JURA Bio, Inc., and also working as a consultant and manager at Clear Creek Bio, Maryline has been instrumental in advancing projects from discovery to preclinical stages, including a partnership with Pfizer. Previous roles include postdoctoral research at Stanford University, where Maryline focused on antiviral agents, and a PhD from ETH Zürich, centered on tuberculosis treatment. Maryline's comprehensive training spans multiple prestigious institutions, where significant contributions were made, particularly in the synthesis and analysis of bioactive compounds across various therapeutic areas.